Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2012
06/21/2012WO2012080462A1 Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses
06/21/2012WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012WO2012079595A1 Herbal composition to treat the hepatic diseases and fibrosis
06/21/2012WO2012079279A1 Pregnane glycoside compounds containing orthoester groups and use thereof
06/21/2012WO2012079146A1 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation
06/21/2012WO2012079121A1 Improved mineral based composition and methods of use
06/21/2012WO2012079118A1 Gastric and colonic formulations and methods for making and using them
06/21/2012WO2012054376A3 Metal ion nanoclusters
06/21/2012US20120157917 High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
06/21/2012US20120157537 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau
06/21/2012US20120157534 Compositions and methods of treatment for inflammatory diseases
06/21/2012US20120157526 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
06/21/2012US20120157523 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/21/2012US20120157502 Phenanthrenone compounds, compositions and methods
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157484 Tryptophan hydroxylase inhibitors
06/21/2012US20120157483 Method for Treating Liver Diseases of Various Origins
06/21/2012US20120157477 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
06/21/2012US20120157475 Combination Preparation Against Vertigo
06/21/2012US20120157469 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157460 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157417 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157408 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
06/21/2012US20120157407 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
06/21/2012US20120157406 Method of preventing diarrhoea
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157399 Bile acid recycling inhibitors for treatment of obesity and diabetes
06/21/2012US20120157397 Trimethylamine-containing compounds for diagnosis and prediction of disease
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156649 Methods for treating dental diseases, disorders, and injuries
06/21/2012US20120156308 Mineral trioxide aggregate (mta) composition and use
06/21/2012US20120156307 Medical uses of nanoclustered water
06/21/2012US20120156293 Antacid and laxative tablet
06/21/2012US20120156263 Ursodeoxycholic Acid-Synthetic Hydrotalcite-Eudragit Hybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the Same
06/21/2012US20120156252 Method of producing microbeads
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156214 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156209 Anti-il-tif antibodies and methods of use
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156192 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/21/2012US20120156181 Therapeutic agent for liver-related diseases
06/21/2012US20120156145 Use of Titanium-Based Materials as Bactericides
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2821219A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012CA2821196A1 Gastric and colonic formulations and methods for making and using them
06/20/2012EP2465579A1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
06/20/2012EP2465506A1 Methods and compositions for treating gastrointestinal disorders
06/20/2012EP2465495A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles
06/20/2012EP2464373A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
06/20/2012EP2464354A1 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
06/20/2012EP2464330A1 Oral care compositions containing human recombinant interleukin-1
06/20/2012EP2464247A2 Nutritional supplements
06/20/2012EP2464230A1 Intravenous formulations of neurokinin-1 antagonists
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP1771151B1 Composition, comprising hydrofluoric acid, for inhibiting dental erosion
06/20/2012CN1550236B Protein stability in aqueous solution
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102510758A Lactase preparation
06/20/2012CN102505022A RNA interference vector capable of simultaneously silencing multiple ligands of NKG2D, and construction method and application thereof
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504989A Male health wine
06/20/2012CN102504043A Active dendrobe polysaccharide capable of protecting liver and resisting liver fibrosis and preparation method of antibody affinity chromatography
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102504006A Steroid saponin compound in siberian fritillary bulb
06/20/2012CN102504005A Compound with novel structure and preparation method and applications thereof
06/20/2012CN102503994A Method of treating clostridium difficile-associated diarrhea
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503925A Flavenes (isoflavene) urease inhibitor and synthesis and purpose thereof
06/20/2012CN102503924A Flavane (isoflavane) urease inhibitor and synthesis and use thereof
06/20/2012CN102503922A Flavanol (isobutene flavanol) urease inhibitor and synthesis and application thereof
06/20/2012CN102503908A Vitamin A acid derivative, preparation method thereof, medicine composition thereof and application thereof to preparation anti-tumor medicine
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102499979A Compound propolis composition for treating dog and cat diarrhea and preparation method thereof
06/20/2012CN102499970A Pure Chinese medicinal composition for treating bovine grainsick and preparation method thereof
06/20/2012CN102499957A Chinese medicinal composition and method for treating diseases related to both liver meridian and large intestine meridian
06/20/2012CN102499953A Process for extracting total phenyl propanoid from paulownia bark of paulownia tomentosa (original variety) by adopting supercritical CO2 fluid technology
06/20/2012CN102499952A Preparation method of Zanthoxylum acanthopodium lignan substances
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499919A Medicine combination containing low sirolimus dose for treating or preventing fibrotic diseases
06/20/2012CN102499915A Drug with Chinese rhubarb acid compound and preparation method of clathrate compound of Chinese rhubarb acid compound
06/20/2012CN102499908A Alvimopan solid preparation and preparation method thereof
06/20/2012CN102499904A Lamellate medicinal bag for treating tooth diseases
06/20/2012CN102499902A Oral cavity care composition
06/20/2012CN102225050B Method for preparing famotidine sodium chloride injection by inclusion method and product prepared by using the same
06/20/2012CN102133224B Compound Iansoprazole chewable tablets
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1258